Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Gastroesophageal cancers: progress and problems.

Literature DB >> 18998257

Gastroesophageal cancers: progress and problems.

Jaffer A Ajani.

Abstract

Entities: Disease

Mesh：

Year: 2008 PMID： 18998257

Source DB: PubMed Journal: J Natl Compr Canc Netw ISSN： 1540-1405 Impact factor: 11.908

Keyword Cloud
Cited

× No keyword cloud information.

14 in total

1. Activation of FOXO3a suggests good prognosis of patients with radically resected gastric cancer.

Authors: Shan Yu; Yiyi Yu; Yihong Sun; Xuefei Wang; Rongkui Luo; Naiqing Zhao; Wen Zhang; Qian Li; Yuehong Cui; Yan Wang; Wei Li; Tianshu Liu
Journal: Int J Clin Exp Pathol Date: 2015-03-01

Review 2. Current advances of targeting HGF/c-Met pathway in gastric cancer.

Authors: Aristomenis Anestis; Ilianna Zoi; Michalis V Karamouzis
Journal: Ann Transl Med Date: 2018-06

3. MET amplification identifies a small and aggressive subgroup of esophagogastric adenocarcinoma with evidence of responsiveness to crizotinib.

Authors: Jochen K Lennerz; Eunice L Kwak; Allison Ackerman; Michael Michael; Stephen B Fox; Kristin Bergethon; Gregory Y Lauwers; James G Christensen; Keith D Wilner; Daniel A Haber; Ravi Salgia; Yung-Jue Bang; Jeffrey W Clark; Benjamin J Solomon; A John Iafrate
Journal: J Clin Oncol Date: 2011-10-31 Impact factor: 44.544

Review 4. Gastric Cancer: New Drugs - New Strategies.

Authors: Nadin Schulte; Matthias P Ebert; Nicola Härtel
Journal: Gastrointest Tumors Date: 2015-03-27

5. The clinicopathological and prognostic significance of PD-L1 expression in gastric cancer: a meta-analysis of 10 studies with 1,901 patients.

Authors: Minghui Zhang; Yuandi Dong; Haitao Liu; Yan Wang; Shu Zhao; Qijia Xuan; Yan Wang; Qingyuan Zhang
Journal: Sci Rep Date: 2016-11-28 Impact factor: 4.379

Review 6. C-Met as a prognostic marker in gastric cancer: a systematic review and meta-analysis.

Authors: Shan Yu; Yiyi Yu; Naiqing Zhao; Jianlan Cui; Wei Li; Tianshu Liu
Journal: PLoS One Date: 2013-11-04 Impact factor: 3.240

7. MET aberrations and c-MET inhibitors in patients with gastric and esophageal cancers in a phase I unit.

Authors: Denis L Fontes Jardim; Debora de Melo Gagliato; Gerald S Falchook; Filip Janku; Ralph Zinner; Jennifer J Wheler; Vivek Subbiah; Sarina A Piha-Paul; Siqing Fu; Mariela Blum Murphy; Jaffer Ajani; Chad Tang; Kenneth Hess; Stanley R Hamilton; Sinchita Roy-Chowdhuri; Razelle Kurzrock; Funda Meric-Bernstam; David S Hong
Journal: Oncotarget Date: 2014-04-15